RTAC: FES/Cerianna Screening for Estrogen Positive MBC
Entities of Cancer, MBC Imaging and Profiling, Medical Community, Novel Treatments, Diagnosis and Treatment, MBC Patients, MBC Stories, Quality of Life Our MBClife Entities of Cancer, MBC Imaging and Profiling, Medical Community, Novel Treatments, Diagnosis and Treatment, MBC Patients, MBC Stories, Quality of Life Our MBClife

RTAC: FES/Cerianna Screening for Estrogen Positive MBC

There’s a FDA- approved diagnostic imaging agent developed to comprehensively evaluate estrogen receptor-positive (ER+) lesions in recurrent or metastatic breast cancer as an adjunct to biopsy. By creating a “whole-body” picture of ER+ lesions, Cerianna may be a helpful diagnostic tool in helping oncologists better determine the most appropriate course of treatment. Learn more in this episode.

Read More